methamphetamine has been researched along with levodopa in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (36.84) | 18.7374 |
| 1990's | 13 (22.81) | 18.2507 |
| 2000's | 16 (28.07) | 29.6817 |
| 2010's | 4 (7.02) | 24.3611 |
| 2020's | 3 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hagino, K; Ikeda, M; Watanabe, H; Watanabe, K | 1 |
| Gibb, JW; Kogan, FJ | 1 |
| Fujiwara, M; Oishi, R; Razzak, A; Ueki, S | 1 |
| Ishikawa, T; Yamamoto, M | 1 |
| Green, AR | 1 |
| Grahame-Smith, DG; Green, AR; Heal, DJ; Kelly, PH | 1 |
| Fujiwara, M; Inoue, K; Ueki, S | 1 |
| Barnett, A; Goldstein, JM; Malick, JB | 1 |
| Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
| Green, AR; Kelly, PH | 1 |
| Wagner, GC; Walsh, SL | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Hotta, K; Mizusawa, H; Morita, S; Nagase, T; Omote, M; Sakai, K; Yamane, M | 1 |
| Cho, F; Kanazawa, I; Kimura, M; Murata, M; Tanaka, Y | 1 |
| Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM | 1 |
| Buckett, WR; Frankland, AT; Heal, DJ | 1 |
| Gibb, JW; Hanson, GR; Ritter, JK; Schmidt, CJ; Sonsalla, PK | 1 |
| Gibb, JW; Hanson, GR; Sonsalla, PK | 1 |
| Davies, CL; Heal, DJ | 1 |
| Grewaal, DS; McGeer, EG; McGeer, PL | 1 |
| Kashiwabara, K | 1 |
| Ricaurte, GA; Schuster, CR; Seiden, LS | 1 |
| Arruda, F; Campos, F | 1 |
| Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ | 1 |
| Elsworth, JD; Lees, AJ; Sandler, M; Stern, GM; Ward, C | 1 |
| Ikoma, H; Kikumoto, R; Tobe, A; Tonomura, S; Yoshida, Y | 1 |
| Lucot, JB; Schuster, CR; Seiden, LS; Wagner, GC | 1 |
| Marshall, JF; O'Dell, SJ; Weihmuller, FB | 1 |
| Kunihara, M; Nakano, M; Ohyama, M | 1 |
| Fisher, H; Myers, CS; Wagner, GC | 1 |
| Hashiguchi, H; Ishida, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K | 1 |
| Bunzow, JR; Chester, JA; Dziewczapolski, G; Falzone, TL; Fang, Y; Gershanik, O; Grandy, DK; Larson, JL; Low, MJ; McDougall, JA; Phillips, TJ; Pugsley, TA; Rubinstein, M; Saez, C; Zhang, G | 1 |
| Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H | 1 |
| Ellis, KL; Speed, J | 1 |
| Camp, DM; LeWitt, PA; Loeffler, DA | 1 |
| Kameda, K; Koyama, T; Kusumi, I; Miura, J; Suzuki, K; Tanaka, T | 1 |
| Avison, MJ; Berger, JR; Maragos, WF; Nath, A; Schmitt, FA | 1 |
| Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M | 1 |
| Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
| Battaglia, G; Capobianco, L; De Blasi, A; Ferrucci, M; Fornai, F; Gesi, M; Lazzeri, G; Lenzi, P; Nicoletti, F; Paparelli, A; Soldani, P | 1 |
| Brooks, DJ; Gerhard, A; Pavese, N; Piccini, P; Rimoldi, O | 1 |
| Falleni, A; Ferrucci, M; Fornai, F; Fulceri, F; Giorgi, FS; Lazzeri, G; Lenzi, P; Paparelli, A; Ruggieri, S | 1 |
| Francescutti-Verbeem, DM; Kuhn, DM; Thomas, DM | 3 |
| Fornai, F; Paparelli, A; Pasquali, L; Ruffoli, R; Ruggieri, S; Soldani, P | 1 |
| Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H | 1 |
| Biagioni, F; Fornai, F; Murri, L; Paparelli, A; Pellegrini, A; Ruggieri, S | 1 |
| Biagioni, F; Fornai, F; Fulceri, F; Murri, L; Paparelli, A; Ruggieri, S | 1 |
| Abe, Y; Hirokawa, S; Kakita, A; Kato, T; Kominami, R; Nawa, H; Ozaki, M; Sotoyama, H; Takahashi, H | 1 |
| Doyle, KM; Kelly, JP; Moreira da Silva Santos, A | 1 |
| Ando, K; Inoue, R; Kawai, K; Nishime, C; Nishinaka, E; Tsutsumi, H; Urano, K | 1 |
| Dimitriou, A; Efthimiou, P; Karveli, M; Lagadinou, M; Skaltsa, M; Tsigkou, A; Velissaris, D; Zareifopoulos, N | 1 |
| Erives, VH; Hamed, MF; Hernandez, H; Manepalli, S; Martinez, LR; Munzen, ME; Nguyen, LN; Nosanchuk, JD; Zamith-Miranda, D | 1 |
| Arai, M; Goshima, Y; Hishimoto, A; Inoue, M; Kanai, K; Masukawa, D; Uchimura, H | 1 |
3 review(s) available for methamphetamine and levodopa
| Article | Year |
|---|---|
Behavioural sensitisation during dopamine replacement therapy in Parkinson's disease is reminiscent of the addicted brain.
Topics: Animals; Behavior, Addictive; Brain; Humans; Levodopa; Methamphetamine; Parkinson Disease | 2009 |
Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.
Topics: Amphetamine-Related Disorders; Animals; Brain; Dopamine; Humans; Levodopa; Methamphetamine; Parkinsonian Disorders; Receptors, Dopamine D1; Signal Transduction | 2009 |
Converging dopaminergic neurotoxicity mechanisms of antipsychotics, methamphetamine and levodopa.
Topics: Antipsychotic Agents; Dopamine; Dopaminergic Neurons; Humans; Levodopa; Methamphetamine; Mitochondria; Neurotoxicity Syndromes; Oxidation-Reduction; Oxidative Stress; Synaptic Transmission | 2021 |
1 trial(s) available for methamphetamine and levodopa
| Article | Year |
|---|---|
Cardiovascular effects of methamphetamine in Parkinson's disease patients.
Topics: Adrenergic Fibers; Analysis of Variance; Blood Pressure; Brain; Catecholamines; Dopamine Agents; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Injections, Intravenous; Levodopa; Male; Methamphetamine; Middle Aged; Myocardium; Parkinson Disease; Presynaptic Terminals; Psychomotor Agitation; Tomography, Emission-Computed | 2004 |
53 other study(ies) available for methamphetamine and levodopa
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Effects of dopaminergic stimulating agents, caffeine and antipsychotic drugs on rotational behaviour in mice with unilateral striatal 6-hydroxydopamine lesions (author's transl)].
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain Diseases; Caffeine; Corpus Striatum; Hydroxydopamines; In Vitro Techniques; Levodopa; Male; Methamphetamine; Methods; Mice; Receptors, Dopamine; Rotation | 1978 |
Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity.
Topics: Adrenal Glands; Animals; Corpus Striatum; Dopamine; Levodopa; Male; Methamphetamine; Methyltyrosines; Rats; Tyrosine 3-Monooxygenase | 1979 |
Possible involvement of a central noradrenergic system in automutilation induced by clonidine in mice.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Caffeine; Catecholamines; Chlorpromazine; Clonidine; Dose-Response Relationship, Drug; Drug Synergism; Fenclonine; Humans; Levodopa; Male; Methamphetamine; Methyltyrosines; Mice; Phenoxybenzamine; Phentolamine; Reserpine; Self Mutilation; Sympathetic Nervous System; Theophylline | 1977 |
Involvement of the cholinergic mechanism in depression of the caudate spindle.
Topics: Animals; Atropine; Cats; Caudate Nucleus; Depression, Chemical; Female; Levodopa; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Physostigmine; Reticular Formation | 1979 |
Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.
Topics: Animals; Apomorphine; Dopamine; Electroshock; Flurothyl; Levodopa; Male; Methamphetamine; Motor Activity; Rats; Serotonin; Stimulation, Chemical; Time Factors; Tranylcypromine | 1978 |
The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
Topics: Adenylyl Cyclases; Amphetamines; Animals; Apomorphine; Caudate Nucleus; Cycloheximide; Dopamine; Drug Interactions; Hydroxydopamines; In Vitro Techniques; Levodopa; Male; Methamphetamine; Motor Activity; Norepinephrine; Pentylenetetrazole; Poly I-C; Rats; Receptors, Dopamine; Sleep; Thyrotropin-Releasing Hormone; Tranylcypromine; Tryptophan | 1976 |
[Behavioral pharmacology of a new antidepressant, lopramine].
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Dibenzazepines; Drug Synergism; Emotions; Humans; Imipramine; Lethal Dose 50; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior | 1976 |
The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Carbidopa; Hindlimb; Levodopa; Male; Methamphetamine; Muscle Rigidity; Rats; Reserpine; Scopolamine; Time Factors; Trihexyphenidyl | 1975 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
Topics: Amphetamines; Animals; Disulfiram; Drug Interactions; Levodopa; Male; Methamphetamine; Motor Activity; p-Chloroamphetamine; Rats; Serotonin; Tranylcypromine | 1976 |
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Dopamine; Fenfluramine; Levodopa; Male; Methamphetamine; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Serotonin | 1992 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
[Pharmacological effects of the novel dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system].
Topics: Animals; Barbiturates; Body Temperature; Catalepsy; Dogs; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Rabbits; Rats; Rats, Inbred Strains; Sleep; Tremor; Tremorine | 1991 |
Choreic movements in the macaque monkey induced by kainic acid lesions of the striatum combined with L-dopa. Pharmacological, biochemical and physiological studies on neural mechanisms.
Topics: Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Chorea; Corpus Striatum; Electrophysiology; Kainic Acid; Levodopa; Macaca fascicularis; Male; Methamphetamine; Movement; Nervous System; Neurons; Neurotransmitter Agents; Volition | 1990 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Levodopa; Male; Methamphetamine; Microinjections; Parkinson Disease; Rats; Sulpiride | 1990 |
A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
Topics: alpha-Methyltyrosine; Animals; Antidepressive Agents; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Antagonists; Electrochemistry; Levodopa; Male; Methamphetamine; Methyltyrosines; Nucleus Accumbens; Pargyline; Rats; Rats, Inbred Strains; Tranylcypromine | 1990 |
Role of dopamine in the neurotoxic effects of methamphetamine.
Topics: alpha-Methyltyrosine; Animals; Brain; Brain Chemistry; Dopamine; Hydroxyindoleacetic Acid; Levodopa; Male; Methamphetamine; Methyltyrosines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1985 |
Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
Topics: 5,7-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Corpus Striatum; Dopamine; Hydroxydopamines; Levodopa; Male; Methamphetamine; Methyltyrosines; Oxidopamine; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Synaptic Transmission; Tryptophan Hydroxylase | 1986 |
Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine.
Topics: Animals; Brain Chemistry; Caudate Nucleus; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Levodopa; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Tranylcypromine | 1986 |
Influence of noncholinergic drugs on rat striatal acetylcholine levels.
Topics: Acetylcholine; Acetylcholinesterase; Acetyltransferases; Amantadine; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Biological Assay; Brain Chemistry; Choline; Corpus Striatum; Depression, Chemical; Haloperidol; Levodopa; Male; Methamphetamine; Rats; Rats, Inbred Strains; Reserpine; Stimulation, Chemical; Tyrosine 3-Monooxygenase | 1974 |
[A long-term qualitative behavioral change following chronic methamphetamine administration in Japanese monkeys (Macaca fuscata)].
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Levodopa; Macaca; Male; Methamphetamine | 1983 |
Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydrazines; Kinetics; Levodopa; Male; Methamphetamine; Putamen; Rats; Rats, Inbred Strains | 1983 |
Pharmacologic manipulations of brain catecholamines and the behavior of Callithrix jacchus (marmoset).
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Callitrichinae; Catecholamines; Female; Haloperidol; Levodopa; Male; Methamphetamine; Methyltyrosines | 1981 |
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine | 1982 |
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.
Topics: Amphetamine; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Levodopa; Methamphetamine; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline | 1982 |
Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Topics: Aggression; Animals; Antidepressive Agents; Behavior, Animal; Benzhydryl Compounds; Catalepsy; Catecholamines; Cats; Drug Interactions; Female; Humans; Levodopa; Male; Methamphetamine; Mice; Parasympatholytics; Rats; Reserpine; Stereotyped Behavior; Tetrabenazine; Yohimbine | 1981 |
The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine.
Topics: Animals; Brain Chemistry; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Methamphetamine; Motor Activity; Rats | 1980 |
L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection.
Topics: Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Drug Synergism; Electrochemistry; Injections; Levodopa; Male; Methamphetamine; Nerve Endings; Nervous System; Rats; Rats, Sprague-Dawley | 1993 |
Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Brain; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Morphine; Motor Activity; Pyrrolidines | 1993 |
Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Haloperidol; Levodopa; Male; Methamphetamine; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotation; Uridine | 1995 |
Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Topics: Animals; Brain Tissue Transplantation; Caudate Nucleus; Corpus Striatum; Dizocilpine Maleate; Dopamine; Female; Fetal Tissue Transplantation; Levodopa; Mesencephalon; Methamphetamine; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Putamen; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 1996 |
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Depressants; Clozapine; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Ethanol; Genotype; Humans; Levodopa; Locomotion; Maternal Behavior; Methamphetamine; Mice; Mice, Knockout; Molecular Sequence Data; Motor Activity; Mutagenesis, Site-Directed; Narcotics; Nucleus Accumbens; Receptors, Dopamine D2; Receptors, Dopamine D4; Sensitivity and Specificity; Substantia Nigra; Transcription, Genetic | 1997 |
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase | 1998 |
Pharmacologic management of movement disorder after midbrain haemorrhage.
Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders | 1998 |
L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
Topics: Animals; Cerebellum; Corpus Striatum; Gentisates; Hydroxybenzoates; Hydroxyl Radical; Injections; Levodopa; Male; Mesencephalon; Methamphetamine; Microdialysis; Osmolar Concentration; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylates; Substantia Nigra | 2000 |
Effects of lithium on dopamine D2 receptor expression in the rat brain striatum.
Topics: Animals; Antidepressive Agents; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Gene Expression Regulation; Hyperkinesis; Levodopa; Lithium Carbonate; Male; Methamphetamine; Neostriatum; Neurons; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Transcription, Genetic; Tritium | 2001 |
Acceleration of HIV dementia with methamphetamine and cocaine.
Topics: Adult; AIDS Dementia Complex; Amphetamine-Related Disorders; Antiretroviral Therapy, Highly Active; Blood-Brain Barrier; Brain; Cholinergic Antagonists; Cocaine-Related Disorders; Disease Progression; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methamphetamine; Movement Disorders | 2001 |
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species | 2002 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |
Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells.
Topics: alpha-Methyltyrosine; alpha-Synuclein; Animals; Antioxidants; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Inclusion Bodies; Levodopa; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Nerve Tissue Proteins; Neurons; PC12 Cells; Rats; Substantia Nigra; Synucleins | 2004 |
Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity.
Topics: Adrenal Medulla; Animals; Catecholamines; Cell Compartmentation; Chromaffin Cells; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Immunohistochemistry; Levodopa; Male; Mesencephalon; Methamphetamine; Microscopy, Electron, Transmission; Neurons; Neurotoxins; PC12 Cells; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Secretory Vesicles; Synaptic Transmission | 2007 |
The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Animals; Body Temperature; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Enzyme Inhibitors; Extracellular Space; Female; Gliosis; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Presynaptic Terminals; Reserpine; Tyrosine 3-Monooxygenase | 2008 |
Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.
Topics: Adrenergic Uptake Inhibitors; Animals; Central Nervous System Stimulants; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Female; Humans; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Neurotoxins; Presynaptic Terminals; Reserpine | 2008 |
Methamphetamine fails to alter the noradrenergic integrity of the heart.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Denervation; Dopamine Agonists; Heart; Humans; Hypotension, Orthostatic; Levodopa; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurotoxins; Norepinephrine; Parkinson Disease | 2008 |
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase | 2009 |
Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
Topics: Animals; Clorgyline; Cytosol; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Neurons; Neurotoxicity Syndromes; Nucleus Accumbens; Plant Lectins; Reserpine; Ribosome Inactivating Proteins; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia.
Topics: Acoustic Stimulation; Animals; Animals, Newborn; Behavior, Animal; Biotinylation; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Hearing; Immunoprecipitation; Levodopa; Locomotion; Methamphetamine; Mice; Microdialysis; Neuregulin-1; Phosphorylation; Potassium; Proto-Oncogene Proteins c-fos; Reflex, Startle; Risperidone; Social Behavior; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2011 |
Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dose-Response Relationship, Drug; Gene Expression Regulation; Homovanillic Acid; Levodopa; Locomotion; Male; Methamphetamine; Nerve Growth Factors; Rats; Rats, Sprague-Dawley; Time Factors | 2017 |
Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine.
Topics: Animals; Apomorphine; Area Under Curve; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Immunohistochemistry; Levodopa; Male; Methamphetamine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; HIV Infections; Humans; Levodopa; Mammals; Melanins; Methamphetamine; Mice; Saccharomyces cerevisiae; Sepsis | 2022 |
Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate.
Topics: Animals; Central Nervous System Stimulants; Dopamine; Levodopa; Methamphetamine; Methylphenidate; Mice; Receptors, Neurotransmitter | 2023 |